Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.97
-0.04 (-0.36%)
At close: May 22, 2026, 4:00 PM EDT
10.99
+0.02 (0.18%)
After-hours: May 22, 2026, 5:28 PM EDT

Design Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12.7716.8622.5621.226.5298.57
Short-Term Investments
210.05202.99222.91260.6303.8985.5
Cash & Short-Term Investments
222.82219.85245.48281.8330.39384.06
Cash Growth
-2.98%-10.44%-12.89%-14.71%-13.98%964.15%
Other Current Assets
4.233.942.562.794.731.37
Total Current Assets
227.05223.78248.04284.58335.12385.44
Net Property, Plant & Equipment
3.392.423.634.635.565.12
Other Long-Term Assets
--0.430.430.46-
Total Assets
230.44226.2252.09289.64341.14390.56
Accounts Payable
2.282.312.191.943.031.62
Accrued Expenses
7.9110.746.287.687.753.66
Total Current Liabilities
10.1913.068.469.6210.785.28
Long-Term Leases
2.20.651.532.333.053.14
Total Long-Term Liabilities
2.20.651.532.333.053.14
Total Liabilities
12.3913.71011.9613.838.43
Common Stock
0.010.010.0100.010.01
Additional Paid-in Capital
532.96509.1468.83455.25441.42429.82
Accumulated Other Comprehensive Income
-0.270.40.480.06-3.36-0.24
Retained Earnings
-314.64-297.01-227.21-177.63-110.76-47.46
Total Common Shareholders' Equity
218.05212.5242.1277.69327.31382.13
Shareholders' Equity
218.05212.5242.1277.69327.31382.13
Total Liabilities & Equity
230.44226.2252.09289.64341.14390.56
Total Debt
2.20.651.532.333.053.14
Net Cash (Debt)
220.63219.2243.94279.46327.34380.92
Net Cash Growth
0.65%-10.14%-12.71%-14.63%-14.07%955.44%
Net Cash Per Share
3.773.824.314.995.888.29
Book Value
218.05212.5242.1277.69327.31382.13
Book Value Per Share
3.733.714.284.965.888.32
Tangible Book Value
218.05212.5242.1277.69327.31382.13
Tangible Book Value Per Share
3.733.714.284.965.888.32
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q